Recent Updates
Recently added Catalysts
PRGO Positive Sentiment

Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference

Key Takeaway: Perrigo Company plc announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference on June 9th. The presentation will be accessible via webcast on Perrigo's website. The company is recognized for its extensive experience in consumer health products.
Price reaction · baseline $11.22 (2026-05-22 close) · hit after-hours · clean, no other PRGO news in the window
day 0 close · peak
-3.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Perrigo's leadership team will present at a significant conference.
  • The company has a strong history in consumer health and wellness.
  • Perrigo's business model supports both private label and leading brands.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+26%
120-day peak, hindsight
Typical move
1.3%
average across 3 past catalysts
Lead asset
Norgestrel
Phase 3 · Contraception

Full Press Release Details

DUBLIN,May 26, 2026/PRNewswire/ -- Perrigo Company plc (NYSE:PRGO), a leading global provider of consumer products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference on Tuesday, June 9th at 10:30 AM EDT.
Interested parties can access the webcast on the Perrigo website athttp://perrigo.investorroom.com/events-webcasts.

About Perrigo

Perrigo Company plc is a leading pure-play consumer health company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe. As a pioneer in the over-the-counter (OTC) self-care market, Perrigo offers trusted self-care solutions that can be used without the need for a prescription, ensuring accessibility and choice for consumers across molecules, dosage forms, and value tiers.
Perrigo's unique business model leverages its complementary businesses, where cash-generative store brand private label offerings fuel investments for leading brands, including Opill®, Mederma®, Compeed®, EllaOne®,and Jungle Formula®.
For more information, visitwww.perrigo.com.

Forward-Looking Statements

This press release includes, and the matters discussed in Perrigo's presentation at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference will include certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements involve known and unknown risks, uncertainties and other factors—many of which are beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available athttps://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.

Perrigo Contact

Frequently Asked Questions

When is Perrigo's presentation at the Oppenheimer Conference?

Perrigo's presentation is scheduled for June 9th at 10:30 AM EDT.

Who will represent Perrigo at the conference?

President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra will present.

How can I access the conference webcast?

The webcast can be accessed on Perrigo's investor relations website.

What is Perrigo known for?

Perrigo is a leading provider of consumer health products, particularly OTC solutions.

Last updated: May 26, 2026